Let’s do a quick tour of some of the latest announcements made by psychedelics companies over the past week. We promise you’ll be informed in less time than it takes to brew your coffee. New, Standardized Magic Mushroom Microdosing Capsules By Red Light Holland And Partner CCrest Labs
Drug discovery company Mindset Pharma (OTCQB: MSSTF) has been greenlighted by the US Patent and Trademark Office (USPTO) on its application “Psilocin Derivatives As Serotonergic Psychedelic Agents for the Treatment of CNS Disorders.”
Clinical-stage natural psychedelics developer Filament Health (OTCQB: FLHLF) and the Psychiatric Center Copenhagen’s collaborative clinical trial has been approved by the Danish Medicines Agency and is set to commence this February.
Lifesciences psychedelics biotech Psyence Group Inc. (OTCQB: PSYGF) recently exported purified pharmaceutical-grade psilocybin mushroom extract from its licensed and certified production facility in Southern Africa to its Contract Development & Manufacturing Organization (CDMO) partner in the UK.
Today, 2:23 PM
U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining over 200 points on Friday. The Dow traded up 0.61% to 33,245.17 while the NASDAQ rose 2.14% to 11,084.83. The S&P 500 also rose, gaining, 1.24% to 3,947.25.
Psychedelics biotech Clearmind Medicine Inc. (NASDAQ: CMND) has successfully completed two drug discovery projects with leading scientists at the Hebrew University of Jerusalem.
Today, 2:23 PM
Genius Group Ltd (NASDAQ: GNS) shares are trading higher by 271.62% to $1.99 Thursday afternoon after the company approved a plan to create an 'Illegal Trading Task